Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells
1Department of Cell Biology, New York University Cancer Institute, New York University School of Medicine, New York, New York 10016, USA.
Abstract:
CD8(+) tumor-infiltrating lymphocytes (TIL) lack in vivo and in vitro lytic function due to a signaling deficit characterized by failure to flux calcium or activate tyrosine kinase activity upon contact with cognate tumor cells. Although CD3 zeta is phosphorylated by conjugation in vitro with cognate tumor cells, showing that TIL are triggered, PLC gamma-1, LAT, and ZAP70 are not activated and LFA-1 is not affinity-matured, and because p56(lck) is required for LFA-1 activation, this implies that the signaling blockade is very proximal. Here, we show that TIL signaling defects are transient, being reversed upon purification and brief culture in vitro, implying a fast-acting "switch". Biochemical analysis of purified nonlytic TIL shows that contact with tumor cells causes transient activation of p56(lck) ( approximately 10 s) which is rapidly inactivated. In contrast, tumor-induced activation of p56(lck) in lytic TIL is sustained coincident with downstream TCR signaling and lytic function. Shp-1 is robustly active in nonlytic TIL compared with lytic TIL, colocalizes with p56(lck) in nonlytic TIL, and inhibition of Shp-1 activity in lytic TIL in vitro blocks tumor-induced defective TIL cytolysis. Collectively, our data support the notion that contact of nonlytic TIL with tumor cells, and not with tumor-infiltrating myeloid-derived suppressor cells, causes activation of Shp-1 that rapidly dephosphorylates the p56(lck) activation motif (Y394), thus inhibiting effector phase functions.
Insights
Tumor-infiltrating lymphocytes (TIL) exhibit transient signaling defects upon tumor cell contact, caused by rapid p56(lck) inactivation mediated by Shp-1 phosphatase. This explains the loss of cytotoxic T cell function in tumors.
Area of Science:
- Immunology
- Cancer Biology
- Cell Signaling
Background:
- CD8(+) tumor-infiltrating lymphocytes (TIL) often display impaired cytotoxic function within the tumor microenvironment.
- This dysfunction is linked to proximal signaling deficits, including a failure in calcium flux and tyrosine kinase activation upon encountering tumor cells.
Purpose of the Study:
- To investigate the transient nature of TIL signaling defects and identify the underlying molecular mechanisms.
- To elucidate the role of specific signaling molecules, such as p56(lck) and Shp-1, in regulating TIL lytic function.
Main Methods:
- Biochemical analysis of purified nonlytic and lytic TIL.
- Assessment of p56(lck) activation kinetics and Shp-1 activity.
- Investigating the colocalization of Shp-1 and p56(lck).
- Inhibition of Shp-1 activity to assess its impact on TIL cytolysis.
Main Results:
- TIL signaling defects are transient and reversible upon purification and brief culture.
- Contact with tumor cells leads to rapid, transient activation and inactivation of p56(lck) in nonlytic TIL.
- In contrast, lytic TIL show sustained p56(lck) activation.
- Shp-1 phosphatase is highly active in nonlytic TIL, colocalizes with p56(lck), and its inhibition restores TIL cytolytic function.
Conclusions:
- Tumor cell contact activates Shp-1 in nonlytic TIL, leading to rapid dephosphorylation and inactivation of p56(lck).
- This Shp-1-mediated inhibition of p56(lck) is a key mechanism underlying the loss of effector functions in CD8(+) TIL.
- The findings highlight a critical regulatory switch controlling cytotoxic T cell activity within the tumor microenvironment.
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tumor Immunotherapy
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

